Mission: Our mission is to build a global, patient-forward, cancer learning network where peer and professional navigators guide patients through the innovations of today’s molecular medicine.
View our program brochure here
PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
Donor Lymphocyte Infusion May Improve Survival in R/R MDS
It's OK Not to Have Full Holiday Spirit During Cancer
The FDA Approves Labeling Update for Sandoz in the Treatment of B-Cell CLL